Lupin Launches Its Version Of Favipiravir Drug To Treat COVID-19

Pharma major Lupin on Wednesday became the latest company to launch its version of the antiviral drug favipiravir to treat COVID-19. The drugmaker informed the exchanges about the same in a filing. " Lipin today announced the launch of its Favipiravir in India under the brand name Covihalt for the treatment of mild to moderate COVID-19. Favipiravir has received authorization from the Drug Controller General of India (DCGI) for emerge...